Xenon Pharmaceuticals Inc... (XENE)
NASDAQ: XENE
· Real-Time Price · USD
38.23
0.27 (0.71%)
At close: Aug 15, 2025, 3:59 PM
38.23
0.00%
After-hours: Aug 15, 2025, 04:42 PM EDT
Xenon Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -251.45M | -234.33M | -213.39M | -199.06M | -188.6M | -182.39M | -175.04M | -163.73M | -147.43M | -125.37M | -113.54M | -91.84M | -82.79M | -78.88M | -65.64M | -59.05M | -37.12M |
Depreciation & Amortization | 2.62M | 2.56M | 2.78M | 3.84M | 3.79M | 3.54M | 3.21M | 1.83M | 1.6M | 1.62M | 1.38M | 1.23M | 1.09M | 906K | 838K | 800K | 736K |
Stock-Based Compensation | 53.49M | 50.72M | 46.3M | 42.04M | 35.78M | 32.37M | 29M | 26M | 22.76M | 20.38M | 17.27M | 14.17M | 11.67M | 10.02M | 8.92M | 7.86M | 6.63M |
Other Working Capital | 673K | n/a | -7.07M | -7.98M | -2.07M | -1.03M | -4.76M | -3.72M | -9.86M | -16.29M | -9.97M | -9.8M | -7.24M | -1.71M | -3.31M | -4.95M | -20.49M |
Other Non-Cash Items | 6.44M | 22.02M | 20.24M | 25.88M | 15.13M | -2.34M | -6.89M | -2.85M | 6.24M | 11.35M | 14.61M | 11.77M | 4.4M | 1.05M | 764K | 174K | 258K |
Deferred Income Tax | -10.3M | -8.68M | -448.97K | -282.97K | -173.97K | -288.97K | -87K | -134K | -14K | -44K | 297K | 233K | 307K | 58K | -333K | -254K | -328K |
Change in Working Capital | 5.65M | n/a | -598.89K | -8.61M | -2.66M | 5.56M | 7.22M | 8.12M | 8.11M | -676K | -732K | -894K | -1.89M | -2.65M | -6.46M | -7.58M | -25.94M |
Operating Cash Flow | -199.86M | -181.39M | -160.69M | -151.77M | -152.32M | -143.55M | -142.59M | -130.77M | -114.41M | -98.43M | -86.41M | -71.01M | -67.22M | -69.5M | -61.91M | -58.05M | -55.77M |
Capital Expenditures | -2.93M | -3.08M | -2.3M | -2.91M | -3.52M | -5.54M | -7.29M | -6.48M | -4.89M | -2.89M | -1.66M | -1.49M | -1.86M | -2.05M | -2.36M | -2.93M | -2.39M |
Cash Acquisitions | n/a | n/a | 236.38M | 187.15M | 157.11M | n/a | -494.4M | -211.46M | -181.43M | -44.6M | 68.68M | -165.03M | -165.03M | -190.71M | -260.67M | -260.67M | -260.67M |
Purchase of Investments | -477.63M | -523.24M | -833.56M | -816.24M | -853.53M | -784.97M | -532.06M | -680.05M | -590.46M | -551.14M | -693.59M | -408.83M | -357.77M | -389.47M | -147.62M | -204.4M | -222.07M |
Sales Maturities Of Investments | 557.33M | 688.16M | 663.17M | 692.51M | 647.61M | 673.89M | 647.58M | 512.62M | 394.86M | 258.03M | 198.14M | 162.9M | 119.08M | 144.75M | 161.84M | 185.59M | 205.46M |
Other Investing Acitivies | 165.75M | 130.79M | -105.53M | -56.31M | -26.28M | 0.51 | 494.4M | 211.46M | 183.29M | 46.46M | -66.82M | 182.69M | 189.93M | 215.61M | 285.56M | 252.53M | 254.73M |
Investing Cash Flow | 245.71M | 165M | -172.68M | -126.63M | -209.45M | -116.63M | 108.22M | -173.91M | -200.49M | -296M | -497.1M | -247.43M | -240.55M | -246.77M | 11.86M | -21.75M | -19M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.2M | 47K | 35K | 35K | 35K | 35K | 6K | 705K | 705K | 705K | 714K | 43K | 154K | 260K | 290K | 262K | -16.57M |
Financial Cash Flow | 13.28M | 12.13M | 320.69M | 350.2M | 350.2M | 350.2M | 29.51M | 705K | 270.6M | 278.47M | 602.42M | 606.48M | 336.7M | 447.54M | 123.64M | 118.88M | 102.05M |
Net Cash Flow | 57.76M | -5.93M | -11.95M | 72.18M | -10.62M | 91.4M | -3.92M | -305.44M | -47.03M | -118.45M | 15.68M | 287.06M | 28.56M | 130.68M | 72.71M | 38.73M | 27.48M |
Free Cash Flow | -202.79M | -184.46M | -162.99M | -154.68M | -155.84M | -149.09M | -149.88M | -137.24M | -119.3M | -101.32M | -88.06M | -72.51M | -69.08M | -71.55M | -64.27M | -60.99M | -58.16M |